Page last updated: 2024-12-06

gyromitrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

gyromitrin: isolated from edible mushroom Gyromitra (Helvella) esculenta; inhalation hallucinogen; highly toxic; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9548611
CHEBI ID5583
SCHEMBL ID2932999
MeSH IDM0047343

Synonyms (39)

Synonym
CHEBI:5583
acetaldehyde n-methyl-n-formylhydrazone
n'-ethylidene-n-methylformohydrazide
hydrazinecarboxaldehyde, ethylidenemethyl-
acetaldehyde, n-formyl-n-methylhydrazone
n-methyl-n-formylhydrazone acetaldehyde
formic acid, ethylidenemethylhydrazide
formic acid, 2-ethylidene-1-methylhydrazide
wln: vhn1&nu2
acetaldehyde n-formyl-n-methylhydrazone
nsc-240877
acetaldehyde n-methylformylhydrazone
nsc240877
brn 1922396
hydrazine carboxyaldehyde, ethylidenemethyl-
hydrazine carboxaldehyde, ethylidenemethyl-
hsdb 3489
ethylidene gyromitrin
ccris 5705
nsc 240877
gyromitrin
C08305
16568-02-8
AKOS006279315
s9j72g0t46 ,
unii-s9j72g0t46
hydrazinecarboxaldehyde, ethylidenemethyl-, (e)-
61748-21-8
gyromitrin [iarc]
gyromitrin [hsdb]
CCG-214846
IMAGWKUTFZRWSB-HWKANZROSA-N
n'-[(e)-ethylidene]-n-methylformic hydrazide #
formic acid, n'-ethylidene-n-methyl-hydrazide
SCHEMBL2932999
n'-[(1e)-ethylidene]-n-methylformohydrazide
DTXSID50872971
n-[(e)-ethylideneamino]-n-methylformamide
BRD-K13037776-001-01-2

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In mice exposed to MMH according to a dosing scheme identical to that reported to induce tumours in this species, O6-methylguanine was present in liver and kidney DNA."( Methylation of rat and mouse DNA by the mushroom poison gyromitrin and its metabolite monomethylhydrazine.
Bergman, K; Hellenäs, KE, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (73.33)18.7374
1990's1 (6.67)18.2507
2000's3 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]